Table 1.
Ligand | Training Type | Cytokines | Proposed effect on T Cell Response | Effect of T Cell on the Induction of Trained Immunity | Clinical Associations | Ref |
---|---|---|---|---|---|---|
BCG | Pro-inflammatory | ↑IL-1β | ↑Th1 | T cells downregulate trained immunity | Protection against infection | (5) |
↑TNF | ↑Th17 | (8) | ||||
↑IL-6 | ↓Tregs | (9) | ||||
↑IL-8 | ||||||
↓IL-10 | ||||||
β-glucan | Pro-inflammatory | ↑IL-1β | ↑Th1 | Unknown | Protection against infection | (6) |
↑TNF | ↑Th17 | (10) | ||||
↑IL-6 | ↓Tregs | |||||
↓IL-10 | ||||||
FHTE | Anti-inflammatory | ↑IL-10 | ↑Tregs | Unknown | Protection against EAE | (11) |
↑IL-1RA | ↓Th1 | (12) | ||||
↓TNF | ↓Th17 | |||||
↓IL-12p40 | ||||||
Adenovirus | Pro-inflammatory | ↑MIP-2 | ↑Th17 | CD8 T cell IFN-γ required to induce trained immunity | Protection against infection (via enhanced neutrophilia) | (13) |
↑KC | ||||||
↑IL-1β | ||||||
LPS | Tolerance | ↑IL-10 | ↑Tregs | Unknown | Sepsis Immunoparalysis | (14) |
↓TNF | ↓Th1 | (15) | ||||
↓IL-6 | ↓Th17 | (16) | ||||
oxLDL | Pro-Inflammatory | ↑TNF | ↑Th-1 | Unknown | Athersclerosis | (17) |
↑IL-6 | ↑Th-17 | |||||
↑IL-8 | ||||||
MuHV-4 | Anti-inflammatory | ↓IL-5 | ||||
↓IL-13 | ↓Th2 | Unknown | Reduced allergic reaction to HDMs | (18) | ||
↓IL-4 | ↑Th1 | |||||
↓IL-6 | ||||||
↓IL-10 |